Biotech Startups
10,073 companies tagged Biotech, with their investors and founders.
resbiotic develops physician-formulated prebiotic, probiotic, and postbiotic supplements alongside microbiome testing to address gut health and chronic conditions. The consumer wellness brand bases its products on clinical trials and scientific research, offering personalized restoration recommendations.
0 investors
0 investors
0 investors
0 investors
0 investors
Resolute Science appears to be a clinical-stage therapeutics company focused on oncology and cancer treatment development. The team includes medical oncologists, regulatory experts, and scientific advisors with experience in phase 1-3 clinical trials and precision medicine.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Retension Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for hypertension and cardiovascular disease. The company's lead compound, RTN-001, is a tissue-targeted PDE5 inhibitor designed to treat resistant hypertension through a differentiated mechanism targeting the central pulmonary vasculature.
0 investors
0 investors
Retrieve Medical develops AI-powered documentation and administrative tools for healthcare providers to reduce documentation burden and improve clinical efficiency. The company combines clinical expertise with machine learning to help providers capture comprehensive patient care records.
0 investors
Retrotope is a clinical-stage biopharmaceutical company developing proprietary therapeutics that down-regulate lipid peroxidation to treat degenerative diseases, including neurodegenerative conditions such as INAD, Friedreich's ataxia, ALS, and PSP, as well as dry age-related macular degeneration. Its drug candidates are based on stabilized polyunsaturated fatty acids from its proprietary drug discovery platform.
0 investors
Revalesio is a clinical-stage pharmaceutical company developing mitochondrial-targeted therapies for stroke and neurodegenerative diseases. The company focuses on treatments that restore mitochondrial health to improve cellular recovery and protect neurons in acute brain injury and aging-related neurological decline.
0 investors
Revel Pharmaceuticals develops enzyme-based therapeutics designed to recognize and reverse molecular damage that accumulates in the body's structural tissue — collagen, elastin, and extracellular matrix — targeting age-related damage that drives disease. The company screens natural enzyme variants against real substrates to identify and engineer them into treatments.
0 investors
0 investors
RevBio Sciences develops Gemini, an intravenously administered formulation of phosphorylated hexaacyl disaccharide (PHAD) designed to reduce inflammation-related damage by reprogramming the innate immune system to respond to stress such as trauma and infection in an attenuated way. The company works in therapeutics and immunology.
0 investors
Reven is a biotech company developing RJX technology to address treatment needs for patients with limited therapeutic options. The company has conducted over a decade of research, including FDA-approved clinical studies and is currently investigating the technology's applications across multiple treatment modalities.
0 investors
0 investors
0 investors
0 investors
0 investors